相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
Nisar A. Amin et al.
CLINICAL CANCER RESEARCH (2017)
Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
Yiming Tu et al.
SCIENTIFIC REPORTS (2017)
Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-κB Signaling Pathway
Naoki Ohtsu et al.
CANCER RESEARCH (2016)
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy
Kirk E. Cahill et al.
NEURO-ONCOLOGY (2016)
Immune phenotypes predict survival in patients with glioblastoma multiforme
Haouraa Mostafa et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
Xuejiao Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
Zeyou Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study
Martin Dreyling et al.
LANCET (2016)
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation
E. Grassilli et al.
ONCOGENE (2016)
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Jean-Philippe Pradere et al.
SCIENCE SIGNALING (2016)
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Jean-Philippe Pradere et al.
SCIENCE SIGNALING (2016)
Targeting NF-kappa B in glioblastoma: A therapeutic approach
Dinorah Friedmann-Morvinski et al.
SCIENCE ADVANCES (2016)
Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import
Mingshan Niu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells
Mingshan Niu et al.
CANCER BIOLOGY & THERAPY (2015)
TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
Bin Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
Evan M. Cherry et al.
MOLECULAR CANCER (2015)
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J. A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling
J. Hu et al.
ONCOGENE (2015)
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
Jennifer A. Woyach et al.
BLOOD (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways (vol 455, pg 1061, 2008)
L. Chin
NATURE (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R. Bonavia et al.
ONCOGENE (2012)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)